Alphamab Oncology
VC Fund
Suzhou, China
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment with multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipelinein oncology/ immunology, and they are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Alphamab Oncology invests in
Stages Alphamab Oncology invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Johannes Nippgen
|
|||
|
Kenneth Kwong
|
|||
Terry Shuai
|
|||
Weihao Xu
|
|||
|
Weihao Xu
|
|||
| See all 6 contacts → | |||
Investment Focus
Industry
- Medical 1 (100%)
- 3D Technology 1 (100%)
- Biotechnology 1 (100%)
- Medical Device 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Johannes Nippgen
Chief Medical Officer
|
Chief Medical Officer | Total investments: 0 | Find email | |
|
Kenneth Kwong
Acting Chief Medical Officer
|
Acting Chief Medical Officer | Total investments: 0 | Find email | |
|
Terry Shuai
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
|
Weihao Xu
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
|
Weihao Xu
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sidi Diagnostics
|
Sidi Diagnostics is a medical technology company that focuses on new molecular diagnostic technologies. | $40M / Venture - Series Unknown / Mar 01, 2020 |
Co-Investors
China Minsheng Investment Group
1 deal together
CICC Capital
1 deal together
Jemincare
1 deal together
Lucion
1 deal together
Qingsong Capital
1 deal together
Sangel Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Alphamab Oncology invest in?
Alphamab Oncology invests primarily in Medical, 3D Technology and Biotechnology startups, most often at Venture - Series Unknown stage. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Alphamab Oncology?
Public channels for Alphamab Oncology include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Alphamab Oncology?
The team at Alphamab Oncology includes Johannes Nippgen (Chief Medical Officer), Kenneth Kwong (Acting Chief Medical Officer) and Terry Shuai (Chief Financial Officer), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
